Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-23T10:37:31.902Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychopharmacology tomorrow: 1984 or The Little Prince?1

Published online by Cambridge University Press:  09 July 2009

C. E. Giurgea
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 14 , Issue 3 , August 1984 , pp. 491 - 496
Copyright
Copyright © Cambridge University Press 1984

References

REFERENCES

Ackenhain, M. & Hippius, H. (1977). Clozapine. In Psychotherapeutic Drugs, Part II: Applications (ed. Usdin, E. and Forrest, I. S.), pp. 923–956. Marcel Dekker: Basle.Google Scholar
Arnt, J., Christensen, A. V., Hyttel, J., Larsen, J. J. & Svendsen, O. (1983). Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity. European Journal of Pharmacology 86, 185–198.CrossRefGoogle Scholar
Bartus, R. T., Dean, R. L., Sherman, K. A., Friedman, E. & Beer, B. (1981). Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiology of Aging 2, 105–111.CrossRefGoogle ScholarPubMed
Boissier, J. R., Dumont, C., Ratouis, R. & Pagny, J. (1961). Tentative de pharmacologie prévìsionnelle dans le domaine des neuroleptiques: action sédative, central et adrénalytique de la N (déméthoxy-3, 4-phénéthyl) N-chloro-2-phényl pipérazine. Archives Internationales de Pharmacodynamie 133, 29–49.Google Scholar
Cantor, S., Trevenen, C., Postuma, R., Dueck, R. & Fjeldsted, B. (1980). Is childhood schizophrenia a cholinergic disease? I. Muscle morphology. Archives of General Psychiatry 37, 658–664.CrossRefGoogle ScholarPubMed
Caulfield, M. P., Higgins, G. A. & Straughan, D. W. (1983). Central administration of the muscaranic receptor subtype – selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. Journal of Pharmacy and Pharmacology 35, 131–132.CrossRefGoogle Scholar
Chiodo, L. A. & Antelman, S. M. (1980 a). Tricyclic antidepressants induce subsensitivity of presynaptic dopamine autoreceptors. European Journal of Pharmacology 64, 203–204.CrossRefGoogle ScholarPubMed
Chiodo, L. A. & Antelman, S. M. (1980 b). Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 210, 799–801.CrossRefGoogle ScholarPubMed
Corkin, S., Davis, K. L., Growdon, J. H., Usdin, E. & Wurtman, J. (1982). Alzheimer's Disease: A Report of Progress in Research, p. 525. Raven Press: New York.Google Scholar
De Boni, V. & Crapper McLachlan, D. R. (1981). Biochemical aspects of SDAT and aluminium as a neuroleptic agent. In Strategies for the Development of an Effective Treatment for Senile Dementia (ed. Crook, T. and Gershon, S.), pp. 215–228. Mark Powley: New York.Google Scholar
Deutsch, J. A. (1973). The Physiological Basis of Memory, p. 439. Academic Press: New York.Google Scholar
Giurgea, C. E. (1972). Vers une pharmacologie de l'activité intégrative du cerveau. Tentative du concept nootrope en psychopharmacologie. Actualités Pharmacologiques 25, 115–156.Google Scholar
Giurgea, C. E. (1981). Fundamentals to a Pharmacology of the Mind, p. 446. C. C. Thomas: Springfield, Ill.Google Scholar
Giurgea, C. E. & Salama, M. (1977). Nootropic drugs. Progress in Neuropsychopharmacology 1, 235–247.CrossRefGoogle Scholar
Giurgea, C. E., Greindl, M. G. & Preat, S. (1981). The contribution of nootropic drugs in the problems of old age.In Proceedings of the Fourth South-East European Neuropsychiatry Conference,Halkidiki, Greece, pp. 137–147.Google Scholar
Giurgea, C. E., Greindl, M. G. & Preat, S. (1982). Experimental dysmnesia induced by 1, 4 but not by 1, 5 benzodiazepines. Drug Development Research Supplement 1, 23–31.CrossRefGoogle Scholar
Greindl, M. G. & Preat, S. (1976). A new model of active avoidance conditioning adequate for pharmacological studies. Archives Internationales de Pharmacodynamie et de Thérapie 223, 168–170.Google ScholarPubMed
Hammer, R., Berrie, C. P., Birdsall, N. J. M., Burgen, A. S. V. & Hulme, E. C. (1980). Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283, 90–92.CrossRefGoogle ScholarPubMed
Jensen, R. A., Martinez, J. L., Vasquez, B. J. & McGaugh, J. L. (1979). Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice. Psychopharmacology 64, 125–126.CrossRefGoogle ScholarPubMed
Jungkunz, G., Engel, R. R., King, U. G. & Kuss, H. J. (1983). Endogenous opiates increase pain tolerance after stress in humans. Psychiatry Research 8, 13–18.CrossRefGoogle ScholarPubMed
Kielholz, P. (ed.) (1973). Masked Depression, p. 307. Huber: Bern.Google Scholar
Krnjevic, K. & Reinhardt, W. (1979). Choline excites cortical neurons. Science 206, 1321–1322.CrossRefGoogle ScholarPubMed
Legros, J. J., Gilot, P., Seron, X., Claessens, J., Adam, A., Moeglen, J. M., Audibert, A. & Berchier, P. (1978). Influence of vasopressin on learning and memory. Lancet i, 41–42.Google Scholar
Lehmann, H. E. (1977). Drugs of the future. In Psychotherapeutic Drugs, Part II: Applications (ed. Usdin, E. and Forrest, I. S.), pp. 1469–1489. Marcel Dekker: Basle.Google Scholar
Marott-Sinex, E. & Merril, C. R. (1982). Alzheimer's disease, Down's syndrome and aging. Annals of the New York Academy of Sciences 396, 199.Google Scholar
Nilsson, J. L. G. & Carlsson, A. (1982). Dopamine-receptor agonist with apparent selectivity for autoreceptors: a new principle for antipsychotic action? Tips August, 322–325.Google Scholar
Olpe, H. R. (1981). The cortical projection of the dorsal raphe nucleus: some electrophysiological and pharmacological properties. Brain Research 216, 61–71.CrossRefGoogle ScholarPubMed
Olpe, H. R. & Lynch, G. S. (1982). The action of piracetam on the electrical activity of the hippocampal slice preparation: a field potential analysis. European Journal of Pharmacology 80, 415–419.CrossRefGoogle ScholarPubMed
Olpe, H. R., Glatt, A., Laszlo, J. & Schellenberg, A. (1980). Some electrophysiological and pharmacological properties of the cortical, noradrenergic projection of the locus coeruleus in the rat. Brain Research 186, 9–19.CrossRefGoogle ScholarPubMed
Poulos, C. X. & Hinson, R. (1982). Pavlovian conditional tolerance to haloperidol catelepsy: evidence of dynamic adaptation in the dopaminergic system. Science 218, 491–492.CrossRefGoogle Scholar
Quinaux, N., Scuvee-Moreau, J. & Dresse, A. (1982). Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants: correlation with reduction of spontaneous firing rate of central monoaminergic neurones. Naunyn-Schmiedebergs Archiv für experimentalle Pathologie und Pharmakologie 319, 66–70.CrossRefGoogle ScholarPubMed
Salkind, M. R., Hanks, G. W. & Silverstone, J. T. (1979). Evaluation of the effects of clobazam, a 1, 5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice. British Journal of Clinical Pharmacology 7, 113S–118S.Google Scholar
Schou, M. (1968). Lithium in psychiatry: a review. Journal of Psychiatric Research 6, 67–95.CrossRefGoogle Scholar
Scuvee-Moreau, J. & Dresse, A. (1982). Effect of amineptine on the firing rate of central monoaminergic neurons in the rat. Archives Internationales de Physiologie et de Biochimie 90, 371–373.CrossRefGoogle ScholarPubMed
Shepherd, M. (1972). The classification of psychotropic drugs. Psychological Medicine 2, 96–110.CrossRefGoogle ScholarPubMed
Soubrie, P., Simon, P. & Boissier, J. R. (1976). Amnésie induite chez le rat par les benzodiazépines lors d'une situation ne faisant pas intervenir de composante nociceptive. Comptes Rendus, Académie des Sciences (Paris) 283D, 203–205.Google Scholar
Timsit-Berthier, M., Mantanus, H., Jacques, M. C. & Legros, J. J. (1980). Utilité de la lysine-vasopressine dans le traitement de l'amnésie post-traumatique. Acta Psychiatrica Belgica 80, 728–747.Google Scholar
Van Praag, H. M. (1977). Depression and Schizophrenia: A Contribution on their Chemical Pathologies. Monograph in Modern Biology. Spectrum: New York.Google Scholar
Wall, P. D. (1982). Segmental mechanisms related to pain. In The Brain in Health and Disease: First World Congress of the IBRO, Abstracts, pp. 223–224. Pergamon Press: New York.Google Scholar
Welch, J., Kim, H., Fallon, S. & Liebman, J. (1982). Do antidepressants induce dopamine autoreceptor subsensitivity? Nature 298, 301–302.Google Scholar
Wilhelm, M. (1977). Recent approaches in psychochemotherapy. In Medicinal Chemistry Vol. 5 (ed. Mathieu, J.), pp. 173–187. Elsevier: Amsterdam.Google Scholar
Wurtman, R. J., Magil, S. G. & Reinstein, D. K. (1981). Piracetam diminishes hippocampal acetylcholine levels in rats. Life Sciences 28, 1091–1093.Google Scholar